{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T17:59:39Z","timestamp":1789495179027,"version":"build-2803163510"},"reference-count":25,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Urol"],"published-print":{"date-parts":[[2010]]},"DOI":"10.4103\/0970-1591.70576","type":"journal-article","created":{"date-parts":[[2010,10,7]],"date-time":"2010-10-07T10:17:46Z","timestamp":1286446666000},"page":"379","source":"Crossref","is-referenced-by-count":20,"title":["Sacral neuromodulation: Therapy evolution"],"prefix":"10.4103","volume":"26","author":[{"given":"JannahH","family":"Thompson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SuzetteE","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"StevenW","family":"Siegel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0970-1591.70576-1","doi-asserted-by":"crossref","unstructured":"Siegel SW, Moeller SE. Sacral Neuromodulation for the Treatment of Overactive Bladder (OAB). Raz S, Rodriquez L, editors. Female Urology. 3 rd ed. Ch. 22. Philadelphia: WB Saunders Company; 2008. p. 266-76.","DOI":"10.1016\/B978-1-4160-2339-5.50071-9"},{"key":"key-10.4103\/0970-1591.70576-2","first-page":"335","volume-title":"The role of neuromodulation in the management of urinary urge incontinence","author":"Abrams","year":"2002","journal-title":"BJU Int"},{"key":"key-10.4103\/0970-1591.70576-3","first-page":"687","volume-title":"Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: results of the OPERA trial","author":"Diokno","year":"2003","journal-title":"Mayo Clin Proc"},{"key":"key-10.4103\/0970-1591.70576-4","first-page":"130","volume-title":"Sacral root stimulation in controlled micturition.Peripheral somatic neuroanatomy and stimulated voiding","author":"Schmidt","year":"1979","journal-title":"Invest Urol"},{"key":"key-10.4103\/0970-1591.70576-5","first-page":"1331","volume-title":"Electrical stimulation in the clinical management of the neurogenic bladder","author":"Tanagho","year":"1988","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.70576-6","doi-asserted-by":"crossref","unstructured":"de Groat WC. Neuroanatomy and Neurophysiology: innervation of the lower urinary tract. female urology. In: Raz S, Rodriguez L, editors. Vol 3. 3 rd ed. Philadelphia, PA: WB Saunders Company; 2008. p. 26-46.","DOI":"10.1016\/B978-1-4160-2339-5.50052-5"},{"key":"key-10.4103\/0970-1591.70576-7","first-page":"1287","volume-title":"Latest technologic and surgical developments in using InterStim TM Therapy for sacral neuromodulation: impact on treatment success and safety","author":"Spinelli","year":"2008","journal-title":"Eur Urol"},{"key":"key-10.4103\/0970-1591.70576-8","first-page":"2268","volume-title":"Changes in brain activity following sacral neuromodulation for urinary retention","author":"DasGupta","year":"2005","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.70576-9","doi-asserted-by":"crossref","unstructured":"Sutherland SE, Siegel SW. Sacral nerve stimulation for overactive bladder symptoms. In: Kreder K, Dmochowski R, editors. The Overactive Bladder Evaluation and Management. Ch 26. London: Informa HealthCare; 2007. p. 303-18.","DOI":"10.3109\/9780203931622-30"},{"key":"key-10.4103\/0970-1591.70576-10","first-page":"2029","volume-title":"Results of sacral neuromodulation therapy for urinary voiding dysfunction: outcomes of a prospective, worldwide clinical study","author":"van","year":"2007","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.70576-11","first-page":"19","volume-title":"Sacral nerve stimulation for voiding dysfunction: One institution\u2032s 11 year experience","author":"Sutherland","year":"2007","journal-title":"Neurourol Urodyn"},{"key":"key-10.4103\/0970-1591.70576-12","first-page":"1905","volume-title":"New sacral neuromodulation lead for percutaneous implantation using local anesthesia: description and first experience","author":"Spinelli","year":"2003","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.70576-13","first-page":"358","volume-title":"Improving neuromodulation technique for refractory voiding dysfunctions: two stage implant","author":"Janknegt","year":"1997","journal-title":"Urology"},{"key":"key-10.4103\/0970-1591.70576-14","first-page":"59","volume-title":"Expanding indications for neuromodulation","author":"Bernstein","year":"2005","journal-title":"Urol Clinics N Am"},{"key":"key-10.4103\/0970-1591.70576-15","first-page":"124","volume-title":"Sacral nerve stimulation in patients with chronic, intractable pelvic pain","author":"Paszkiewicz","year":"2001","journal-title":"Urology"},{"key":"key-10.4103\/0970-1591.70576-16","first-page":"11","volume-title":"Long term outcome of sacral nerve stimulation for fecal incontinence","author":"Altomare","year":"2009","journal-title":"Dis Colon Rectum"},{"key":"key-10.4103\/0970-1591.70576-17","first-page":"306","volume-title":"Sacral neuromodulation for the dysfunctional elimination syndrome: a single center experience with 20 children","author":"Roth","year":"2008","journal-title":"J Urol"},{"key":"key-10.4103\/0970-1591.70576-18","first-page":"643","volume-title":"Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial","author":"Peters","year":"2005","journal-title":"Neurourol Urodyn"},{"key":"key-10.4103\/0970-1591.70576-19","first-page":"461","volume-title":"Costs of urinary incontinence and overactive bladder in the united states: a comparative study","author":"Hu","year":"2004","journal-title":"Urology"},{"key":"key-10.4103\/0970-1591.70576-20","first-page":"CD005429","volume-title":"Which Anticholinergic Drug for Overactive Bladder Symptoms in Adults","author":"Hay-Smith","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0970-1591.70576-21","first-page":"1069","volume-title":"sacral neuromodulation: cost considerations and clinical benefits","author":"Aboseif","year":"2007","journal-title":"Urology"},{"key":"key-10.4103\/0970-1591.70576-22","first-page":"418","volume-title":"Botulinum neurotoxins: mechanisms of action and therapeutic applications","author":"Montecucco","year":"1996","journal-title":"Mol Med Today"},{"key":"key-10.4103\/0970-1591.70576-23","first-page":"CD005493","volume-title":"Botulinum toxin injections for adults with overactive bladder syndrome","author":"Duthie","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"key-10.4103\/0970-1591.70576-24","first-page":"1509","volume-title":"Improvement in quality of life after botulinum toxin-a injections for idiopathic detrusor overactivity: results from a randomized double-blind placebo-controlled trial","author":"Sahai","year":"2009","journal-title":"BJU Int"},{"key":"key-10.4103\/0970-1591.70576-25","first-page":"519","volume-title":"Cost- Consequence Analysis Evaluating the Use of Botulinum Neurotoxin-A in Patients with Detrusor Overactivity Based on Clinical Outcomes Observed at a Single UK Centre","author":"Kalsi","year":"2006","journal-title":"Eur Urol"}],"container-title":["Indian Journal of Urology"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:50:44Z","timestamp":1786632644000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0970-1591.70576"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010]]},"references-count":25,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2010]]}},"alternative-id":["70576"],"URL":"https:\/\/doi.org\/10.4103\/0970-1591.70576","relation":{},"ISSN":["0970-1591"],"issn-type":[{"value":"0970-1591","type":"print"}],"subject":[],"published":{"date-parts":[[2010]]}}}